Mach7 Technologies said today that it closed its $60 merger with 3D Medical (ASX:3DM), saying it will begin trading on the Australian Stock Exchange under the “M7T” symbol.
The deal unites Mach7’s enterprise image management offerings with 3D Medical’s medical 3D printing.
“Our commitment to customer-driven design remains the core of our culture and the soul of our business philosophy,” Mach7 managing director & CEO Albert Liong said in prepared remarks. “We are a company born of innovation and growing through extraordinary collaboration to bring advanced enterprise data management and medical solutions to our expanding network of customers, healthcare communities and globally connected healthcare ecosystems.”
“The combined strength of our 2 organizations will enhance our ability to serve a large healthcare market with ground-breaking medical technology applications for improved patient care,” added CFO Jenni Pilcher.
Mach7 said it plans to keep its headquarters in Burlington, Vt., as it looks to expand its sales footprint in Australia, New Zealand and Western Europe.
